Welldoc’s BlueStar Integration with Xealth Improves Patient Engagement by 2.5X

Welldoc Awarded 8th FDA Clearance for Bluestar Medical Device for Diabetes –

Welldoc’s BlueStar Integration with Xealth Improves Patient Engagement by 2.5X

What You Should Know:

Marks 8th FDA clearance for BlueStar, the only
reimbursable software as a medical device for diabetes that integrates with all
of a patient’s existing devices.

Welldoc, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, announced today that the U.S. Food and Drug Administration (FDA) has cleared an additional feature for the digital health product BlueStar Rx which supports individuals using long-acting insulin. The Insulin Adjustment Program (IAP), supports the process of basal insulin titration by health care providers for adults with type 2 diabetes. Patients who are prescribed IAP as part of BlueStar, will benefit from the ease of real-time adjustments to their insulin.

BlueStar is the only FDA cleared and reimbursable
Software as a Medical Device that works with a patient’s existing devices.
Patients can seamlessly integrate BlueStar with blood glucose monitors, blood
pressure cuffs, or fitness trackers, improving convenience and reducing out of
pocket costs. BlueStar, backed by more than 45 peer-reviewed clinical posters
and publications, also:

– Engages people with Type 1 and Type 2 diabetes;

– Delivers tailored, real-time feedback – 24/7, on or offline – to improve long-term health;

– Connects users with their own care team to provide new opportunities to optimize care;

– Seamlessly integrates with blood glucose meters, pharmacies, labs, activity and fitness trackers;

– Aggregates critical data to assist by delivering actionable insights to the user’s care team;

– Allows providers to use remote patient monitoring codes for reimbursement.

“With BlueStar’s Insulin Adjustment Program, a provider prescribes a safe starting dose of insulin for his or her patient, and BlueStar does the rest,” said Dr. Mansur Shomali, Welldoc’s Chief Medical Officer. “The patient no longer has to wait to talk to his or her provider to adjust the insulin. The next time the patient meets with his or her health care provider, the insulin dose has been optimized and they can spend their visit focusing on other important elements of the patient’s care.”

— to hitconsultant.net

Related Articles

Peloton Launches on the Roku Platform to Bring the Industry Leading Interactive Fitness Platform to Roku Users

SAN JOSE, Calif.–(BUSINESS WIRE)–Roku, Inc. (NASDAQ: ROKU) announced the availability of the Peloton App on the Roku® platform starting today. Roku users in the U.S. can add the Peloton channel via the Roku Channel Store and enjoy studio-style workouts in their living rooms – even without a Peloton Bike or Tread. A pioneer in connected, […]
Read more

Fry Family YMCA | Summer Camp | FItness Classes

The mission of the Fry Family YMCA is to develop strong children, families and communities across Naperville through academic readiness, character development, violence prevention, and fitness and healthy living. Our impact is felt every day when an individual makes a healthy choice, when a mentor inspires a child, and when a community comes together for […]
Read more

Lincoln nearing 2,000 COVID-19 cases | Health and Fitness

Lincoln added 51 lab-confirmed cases of COVID-19 on Thursday, bringing the community total to 1,998. The number of deaths remains at 13. Total recoveries remain at 714, according to the daily report from Mayor Leirion Gaylor Baird and the Lincoln-Lancaster County Health Department. The overall positivity rate for testing in Lancaster County was slightly up […]
Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Search for: